Viewing StudyNCT00034281



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034281
Status: COMPLETED
Last Update Posted: 2012-02-02
First Post: 2002-04-24

Brief Title: Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2
Sponsor: Takeda
Organization: Takeda

Conditions & Keywords Data

Conditions:
Name
Renal Neoplasm
Breast Neoplasm
Pancreatic Neoplasm
Lung Neoplasm
Ovarian Neoplasm
Keywords:
Name View
Cancer View
Gene HER2 View
Clinical Trial Phase I View
Breast neoplasm View
Pancreatic neoplasm View
Ovarian neoplasm View
Colorectal neoplasm View
Renal neoplasm View
Prostate neoplasm View